Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cambrex Corp (CBM)

Cambrex Corp (CBM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,023,102
  • Shares Outstanding, K 33,724
  • Annual Sales, $ 532,090 K
  • Annual Income, $ 92,420 K
  • 60-Month Beta 2.13
  • Price/Sales 3.80
  • Price/Cash Flow 15.36
  • Price/Book 2.99
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.60
  • Most Recent Earnings 0.31 on 05/02/19
  • Next Earnings Date 11/14/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 14.000 on 05/04/07
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +2,497,400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.72 +0.45%
on 11/04/19
59.99 unch
on 12/03/19
+0.19 (+0.32%)
since 11/01/19
3-Month
59.38 +1.03%
on 10/02/19
60.14 -0.25%
on 09/06/19
+0.43 (+0.72%)
since 09/03/19
52-Week
33.80 +77.49%
on 02/14/19
60.29 -0.50%
on 08/14/19
+10.73 (+21.78%)
since 12/03/18

Most Recent Stories

More News
Cambrex Announces Completion of Acquisition by the Permira Funds

Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced the completion of its...

CBM : 59.99 (unch)
Shares of Waters Corp Rank the Highest in Terms of Relative Performance in the Life Sciences Tools & Services Industry (WAT , CBM , TMO , ILMN , A )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

CBM : 59.99 (unch)
TMO : 320.50 (+0.36%)
WAT : 234.11 (+0.18%)
Old Dominion Freight Line Set to Join S&P 500; Cabot Microelectronics to Join S&P MidCap 400; Ready Capital and Industrial Logistics Properties Trust to Join S&P SmallCap 600

S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600:

ODFL : 186.41 (-0.57%)
STI : 70.13 (+1.26%)
CCMP : 136.90 (+0.26%)
RC : 15.23 (unch)
BBT : 54.24 (+1.40%)
ILPT : 20.29 (-0.39%)
CBM : 59.99 (unch)
SPGI : 271.20 (+0.34%)
ALXN vs. CBM: Which Stock Should Value Investors Buy Now?

ALXN vs. CBM: Which Stock Is the Better Value Option?

ALXN : 110.42 (-1.82%)
CBM : 59.99 (unch)
Cambrex Wins Third API Development Award at CPhI Worldwide

Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, has won the 'Excellence in Pharma: API...

CBM : 59.99 (unch)
Genesis Healthcare (GEN) to Post Q3 Earnings: What to Expect

Genesis Healthcare's (GEN) third-quarter results are likely to reflect weak revenues, partially offset by same store facility growth and lower expenses.

CBM : 59.99 (unch)
GEN : 1.53 (-5.56%)
ACB : 2.63 (+1.15%)
NGM : 18.67 (+2.02%)
ALXN or CBM: Which Is the Better Value Stock Right Now?

ALXN vs. CBM: Which Stock Is the Better Value Option?

ALXN : 110.42 (-1.82%)
CBM : 59.99 (unch)
Cambrex Releases Selected Preliminary Third Quarter 2019 Financial Results

Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that in connection with...

CBM : 59.99 (unch)
ALXN vs. CBM: Which Stock Should Value Investors Buy Now?

ALXN vs. CBM: Which Stock Is the Better Value Option?

ALXN : 110.42 (-1.82%)
CBM : 59.99 (unch)
Neogenomics Inc is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (NEO , CBM , PKI , BRKR , PACB )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

CBM : 59.99 (unch)
NEO : 26.42 (-0.75%)
PKI : 94.39 (-1.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade CBM with:

Business Summary

Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients...

See More

Key Turning Points

2nd Resistance Point 60.00
1st Resistance Point 59.99
Last Price 59.99
1st Support Level 59.98
2nd Support Level 59.98

See More

52-Week High 60.29
Last Price 59.99
Fibonacci 61.8% 50.17
Fibonacci 50% 47.04
Fibonacci 38.2% 43.92
52-Week Low 33.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar